Redeye comments on Climeon’s Q3 figures that posted a variety of deviations from our estimates. The company delivered four units vs. expected three, explaining a higher-than-expected sales level. The cost mix also deviated, while still resulting in an EBITDA loss ~16% above expectations. More importantly, the progress in signing new deals has been below our expectations and we will adjust Climeon’s growth curve for the coming years. This will result in a material impact on our forecast and valuation.
LÄS MER